JMP Securities Reiterates Market Outperform Rating for MacroGenics (NASDAQ:MGNX)

JMP Securities restated their market outperform rating on shares of MacroGenics (NASDAQ:MGNX – Free Report) in a research report report published on Thursday, Benzinga reports. A number of other research firms have also recently commented on MGNX. BTIG Research boosted their price target on shares of MacroGenics from $12.00 to $24.00 and gave the stock […]

Related Keywords

United States ,Ezio Bonvini ,Jeffrey Stuart Peters ,Barclays ,Group Plc ,Exome Asset Management ,Perceptive Advisors ,Citigroup ,Barclays Plc ,Securities Exchange Commission ,Macrogenics Inc ,Free Report ,Moderate Buy ,Get Free Report ,Exchange Commission ,Stuart Peters ,Asset Management ,General Group Plc ,Macrogenics Daily ,Macrogenics ,Nasdaq Mgnx ,Mgnx ,Medical ,Reiterated Rating ,Jmp Securities ,